全文获取类型
收费全文 | 756篇 |
免费 | 41篇 |
国内免费 | 5篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 24篇 |
妇产科学 | 13篇 |
基础医学 | 67篇 |
口腔科学 | 12篇 |
临床医学 | 51篇 |
内科学 | 157篇 |
皮肤病学 | 9篇 |
神经病学 | 29篇 |
特种医学 | 87篇 |
外科学 | 116篇 |
综合类 | 51篇 |
预防医学 | 64篇 |
眼科学 | 32篇 |
药学 | 35篇 |
肿瘤学 | 47篇 |
出版年
2023年 | 2篇 |
2022年 | 9篇 |
2021年 | 15篇 |
2020年 | 10篇 |
2019年 | 9篇 |
2018年 | 24篇 |
2017年 | 19篇 |
2016年 | 10篇 |
2015年 | 10篇 |
2014年 | 21篇 |
2013年 | 39篇 |
2012年 | 20篇 |
2011年 | 34篇 |
2010年 | 32篇 |
2009年 | 27篇 |
2008年 | 16篇 |
2007年 | 29篇 |
2006年 | 49篇 |
2005年 | 28篇 |
2004年 | 58篇 |
2003年 | 29篇 |
2002年 | 27篇 |
2001年 | 15篇 |
2000年 | 15篇 |
1999年 | 6篇 |
1998年 | 29篇 |
1997年 | 28篇 |
1996年 | 22篇 |
1995年 | 30篇 |
1994年 | 17篇 |
1993年 | 8篇 |
1992年 | 10篇 |
1991年 | 4篇 |
1990年 | 5篇 |
1989年 | 15篇 |
1988年 | 14篇 |
1987年 | 10篇 |
1986年 | 10篇 |
1985年 | 3篇 |
1984年 | 5篇 |
1983年 | 8篇 |
1982年 | 3篇 |
1981年 | 7篇 |
1980年 | 6篇 |
1979年 | 2篇 |
1978年 | 7篇 |
1977年 | 4篇 |
1967年 | 1篇 |
1966年 | 1篇 |
排序方式: 共有802条查询结果,搜索用时 15 毫秒
101.
102.
103.
104.
Pancreatic transplant imaging 总被引:1,自引:0,他引:1
Yuh WT; Wiese JA; Abu-Yousef MM; Rezai K; Sato Y; Berbaum KS; Kao SC; Hunsicker LG; Corry RJ 《Radiology》1988,167(3):679-683
Forty-four clinical episodes of suspected (pancreas) transplant rejection in 17 pancreatic transplantation patients were reviewed retrospectively. The clinical impression of acute graft rejection, chronic rejection, or nonrejection in each episode was correlated with the results of 19 nuclear medicine, 12 ultrasound (US), and 44 magnetic resonance (MR) imaging studies. US was found to be a moderately sensitive (82%) method of detecting graft rejection. US also was effective in identifying intra- and peripancreatic fluid accumulations. Nuclear medicine imaging was also a sensitive technique (86%) and the only modality that provided physiologic information regarding graft perfusion. MR imaging allowed correct prediction of the presence or absence of graft rejection in 39 of 44 cases (sensitivity, 100%; specificity, 76%) and was an effective means of detecting pathologic fluid collections. Nuclear medicine, US, and MR imaging are all believed to be sensitive methods of detecting graft rejection and are complementary adjuncts to the clinical evaluation of pancreatic transplants. 相似文献
105.
Rosen BR; Fleming DM; Kushner DC; Zaner KS; Buxton RB; Bennet WP; Wismer GL; Brady TJ 《Radiology》1988,169(3):799
106.
Recurrence of Helicobacter pylori infection after several eradication therapies: long-term follow-up of 1000 patients 总被引:2,自引:0,他引:2
Gisbert JP Luna M Gómez B Herrerías JM Monés J Castro-Fernández M Sánchez-Pobre P Cosme A Olivares D Pajares JM 《Alimentary pharmacology & therapeutics》2006,23(6):713-719
AIM: To study the incidence of Helicobacter pylori recurrence, its chronological aspects, and the variables that might influence it. METHODS: A total of 1000 patients in whom H. pylori had been eradicated were prospectively studied. Therapies were classified as low and high efficacy regimens. Four to eight weeks after completion of therapy, 13C-urea-breath-test was performed, and it was repeated yearly up to 5 years. In some patients, endoscopy with biopsies was also performed to confirm H. pylori eradication. RESULTS: A total of 1000 patients were included, giving 2744 patient-years of follow-up. Seventy-one H. pylori recurrences were observed (2.6% per patient-year). Probability of being H. pylori-negative at 1 year was 94.7%, and at 5 years 90.7%. In the multivariate analysis, low age (OR: 1.84; 95% CI: 1.04-3.26) and low efficacy therapies (OR: 2.5; 1.23-5.04) correlated with 1-year H. pylori recurrence. Differences were observed when Kaplan-Meier curves were compared depending on age and therapy regimen. CONCLUSION: Risk of posteradication H. pylori recurrence is higher during the first year, which suggests that most recurrences during this period are recrudescence and not true reinfections. H. pylori recurrence is more frequent in younger patients and in those treated with low efficacy therapies, but is exceptional if high efficacy therapies are used, in which case post-therapy eradication can be safely confirmed at 4 weeks with 13C-urea-breath-test. 相似文献
107.
108.
In order to determine the natural evolution of different clinical types of "unstable angina", 167 patients were included in a prospective study. After angiography, 11 (6.5%) were excluded because they had no significant coronary lesions. The remaining 156 were sorted into different groups according to their clinical characteristics and were followed up for a period of 24 months at least. After that follow-up period, mortality and incidence of acute myocardial infarction (AMI) were as follows: angina of recent onset (Class III--IV NYHA): 8.5% (3/35) and 34.2% (12/35). Progressive angina: 7.4% (2/27) and 7.4% (2/27). Intermediate syndrome: 41.6% (10/24) and 37.5% (9/24). Prinzmetal's angina: 10% (1/10) and 10% (1/10). Post acute myocardial infarction angina: 35% (7/20) and 10% (2/20). Acute persistent ischemia: 2.5% (1/40) and 20% (8/40). Comparison of these figures pointed out significant differences (p less than 0.001 for mortality and p less than 0.03 for AMI incidence respectively). We conclude that it is clinically possible to identify different groups within the so-called unstable angina. Such a division not only allows for the creation of more homogeneous groups, but it contributes to a more rational therapeutic approach and also permits identification of high risk prodromes of greater complications, such as myocardial infarction or sudden death. 相似文献
109.
110.
Tumor necrosis factor alpha promotes invasiveness of cholangiocarcinoma cells via its receptor, TNFR2 总被引:1,自引:0,他引:1
Tanimura Y Kokuryo T Tsunoda N Yamazaki Y Oda K Nimura Y Naing Mon N Huang P Nakanuma Y Chen MF Jan YY Yeh TS Chiu CT Hsieh LL Hamaguchi M 《Cancer letters》2005,219(2):205-213
We studied the effect of TNF-alpha stimulation on a cholangiocarcinoma cell line, CCKS1. CCKS1 expressed only one type TNF receptor, TNFR2. Treatment of CCKS1 with TNF-alpha substantially activated NFkappaB, MAPK and Akt signalings which in turn activated matrix metalloproteinase-9 (MMP-9) secretion and in vitro invasiveness of CCKS1. Pretreatment of cells with anti-TNFR2 neutralizing antibody inhibited the TNF-alpha-dependent signaling and MMP-9 secretion and subsequently blocked invasion in vitro. Moreover, an inhibitor for matrix metalloproteinase, Galardin, suppressed the invasion in a dose-dependent manner. Similarly, pharmacological inhibition of signaling clearly suppressed the TNF-alpha dependent MMP-9 secretion. These results strongly suggest that TNF-alpha-TNFR2 signaling plays an important role to convert the cholangiocarcinoma cells to be more aggressive one. 相似文献